Papers/PMID:34294550
The Effects of Cholecalciferol Supplementation on FGF23 and α-Klotho in Hemodialysis Patients With Hypovitaminosis D: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation2022The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
calciol — increases serum 25-hydroxyvitamin D concentration
Evidence strength: very limited.Findingreplicated ×33“Serum 25OH(D) levels increased in participants who received cholecalciferol supplementation compared with participants who received placebo (P = .006).”
Quoted verbatim from The Effects of Cholecalciferol Supplementation on FGF23 and α-Klotho in Hemodialysis Patients With Hypovitaminosis D: A Randomized, Double-Blind, Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- 50,000 IU cholecalciferol weekly for 12 weeks
- Population
- Hemodialysis patients with hypovitaminosis D
The Effects of Cholecalciferol Supplementation on FGF23 and α-Klotho in Hemodialysis Patients With Hypovitaminosis D: A Randomized, Double-Blind, Placebo-Controlled Trial.2022PMID:3429455010.1053/j.jrn.2021.05.006Permalink